Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT03752892
What this trial is testing

Partitioned Training of Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Lung; Disease, Interstitial, With Fibrosis
West Park Healthcare Centre 50
Not applicableStudy completedNCT04187079
What this trial is testing

Immunopathologic Profiles and Blood Biomarkers in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Aarhus 100
Testing effectiveness (Phase 2)Study completedNCT03538301
What this trial is testing

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Nitto Denko Corporation 123
Large-scale testing (Phase 3)Ended earlyNCT04594707
What this trial is testing

Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 117
Early research (Phase 1)Study completedNCT03981094
What this trial is testing

The Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Bristol-Myers Squibb 22
Not applicableStudy completedNCT04838275
What this trial is testing

IPF mHealth Exercise Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Washington 32
Very early researchStudy completedNCT03183570
What this trial is testing

Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT

Who this might be right for
Idiopathic Pulmonary FibrosisPrimary Sclerosing CholangitisCovid19 Pneumonia
Stanford University 21
Testing effectiveness (Phase 2)Study completedNCT02345070
What this trial is testing

Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sanofi 327
Not applicableStudy completedNCT04614441
What this trial is testing

NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 214
Not applicableStudy completedNCT01777373
What this trial is testing

Conducting Airways in Lung Fibrosis (VACFI)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 141
Testing effectiveness (Phase 2)Study completedNCT05130970
What this trial is testing

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
CSL Behring 81
Not applicableUnknownNCT04019080
What this trial is testing

Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden

Who this might be right for
Idiopathic Pulmonary Fibrosis
Karolinska University Hospital 400
Large-scale testing (Phase 3)Looking for participantsNCT07687459
What this trial is testing

Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
InSilico Medicine Hong Kong Limited 320
Testing effectiveness (Phase 2)Study completedNCT00532233
What this trial is testing

SD, IL-13 Production Rate in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 52
Not applicableLooking for participantsNCT05842681
What this trial is testing

Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Assiut University 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05983471
What this trial is testing

Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisCoughIPF+3 more
Melius Pharma AB 40
Testing effectiveness (Phase 2)Looking for participantsNCT07516951
What this trial is testing

Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Chiesi Farmaceutici S.p.A. 240
Not applicableEnrolling By InvitationNCT04016181
What this trial is testing

The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseAsbestosis
University of Edinburgh 800
Not applicableActive Not RecruitingNCT03457935
What this trial is testing

Detection of Early Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Temple University 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT06588686
What this trial is testing

A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Vicore Pharma AB 378
Next Page